Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-07

European network for the examination of clinical and biological implications of respiratory muscles failure in patients with chronic obstructive pulmonary disease

Obiettivo

Objectives:
To enhance knowledge of the structural and functional basis of respiratory muscle (RM) dysfunction/failure and to develop new tools for the management of this condition.

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality in the European Union, being mainly characterized by a progressive airflow limitation. Respiratory Muscles (RM) play a relevant role in the life of patients suffering from COPD since their dysfunction/failure influences the presence and severity of the exacerbations and constitutes a limiting factor for their exercise tolerance. For these reasons, although no specific studies have been carry out, it is believed that RM function also affects the quality of life of such patients. The RM function in COPD is mainly altered by changes in the configuration of the thorax due to pulmonary hyperinflation. This results in shortening of the diaphragm with the impairment in its force-length relationships and a decrease in its resistance to fatigue. In addition, there is a in balance between ventilatory requirements and nutritional supply to RM in COPD patients. All these points taken together, the dysfunction/failure of RM appears as an important cause of the high socio-sanitary and human costs derived from this chronic disease. However, to date there is a lack of adequate instruments for diagnosing RM dysfunction/failure in clinical conditions.

Furthermore,theunderlyingbiologicalmechanismsassociatedwiththis process also remain unclear. This is probably the reason that explains why the treatments directed to improve the RM function in COPD (e.g. pulmonary rehabilitation or non-invasive mechanical ventilation) have been employed empirically and with controversial results.

The main objective of the ERESMUS in COPD project is to enhance knowledge of the structural and functional basis of RM dysfunction/failure, developing at the same time new diagnostic tools for this condition.

This will allow us to better identify patients at risk, selecting them for more specific treatments. The project includes studies in patients with COPD, as well as animal, experimental and theoretical models. This multiple design will make it possible to establish the underlying structural findings associated with RM dysfunction/failure, evaluating the effects of different treatments such as pulmonary rehabilitation or surgical reduction of lung volume. Studies including COPD patients will also permit us to assess the usefulness of the new diagnostic methods. On the other hand, the impact of RM dysfunction/failure and some of its treatments on the quality of life of COPD patients will also be evaluated. Finally, new therapeutic strategies, pharmacological (e.g. mechano growth factor) as well as mechanical (design of a new ventilator controlled by the activity of RM of the patient) will be investigated to develop novel strategies of treatment for RM dysfunction/failure.

To accomplish all these objectives the ERESMUS in COPD project brings together scientists from four different European countries (Spain, United Kingdom, Sweden and Poland) and Canada. These partners work in different disciplines (from basic to clinical sciences) and belong to different institutions, including research centres, hospitals, universities and industrial companies. This multidisciplinary network has the additional objective of strengthening relationships between different partners for further collaborative research. This is the first project tackling the problem of RM dysfunction/failure in COPD from such a multidisciplinary point of view, adding efforts to improve the quality of life of the patients, to reduce socio sanitary costs derived from this condition and to develop new technologies for its diagnosis and treatment.03 03

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CSC - Cost-sharing contracts

Coordinatore

Ayuntamiento de Barcelona
Contributo UE
Nessun dato
Indirizzo
80,C/ Dr. Aiguader
08003 Barcelona
Spagna

Mostra sulla mappa

Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato

Partecipanti (4)

Il mio fascicolo 0 0